Verified Nov 2026
Other
·
Helsinki, Uusimaa
·
Since 2015
Nanoform is a biotechnology and nanotechnology company founded in 2015 and headquartered in Helsinki, Finland, with 100–200 employees. It specializes in nanoparticle engineering and drug formulation services for the pharmaceutical, automotive, electric vehicle, medical, and renewable energy industries. The company operates proprietary CESS® technology to create active pharmaceutical ingredient nanoparticles as small as 10 nanometers, and recently secured its first exclusivity agreement for ultra-high concentration subcutaneous delivery applications.
Nanoform at a glance
Revenue
<$10M
Est. band
Employees
100-200
Founded
2015
Headquarters
Helsinki, Uusimaa
Industries
Automotive
Electric Vehicles
Medical
Renewable Energy
Industrial Equipment
Overview
Nanoform is a biotechnology and nanotechnology company founded in 2015 and headquartered in Helsinki, Finland, with 100–200 employees. It specializes in nanoparticle engineering and drug formulation services for the pharmaceutical, automotive, electric vehicle, medical, and renewable energy industries. The company operates proprietary CESS® technology to create active pharmaceutical ingredient nanoparticles as small as 10 nanometers, and recently secured its first exclusivity agreement for ultra-high concentration subcutaneous delivery applications.
At a glance
Attribute | Detail |
|---|---|
Founded | 2015 |
Headquarters | Helsinki, Uusimaa |
Employees | 100-200 |
Revenue | <$10M (estimated) |
What Nanoform makes
The company provides formulation development, analytical support, and scalable GMP manufacturing services, with capabilities in polymorph control, protein nanoengineering, and nanoformulation for biologics and high potency active pharmaceutical ingredients.
Products and capabilities described on the company's own site include LED (source: nanoform.com).
Latest developments
2026-08-20 — Nanoform Q2 2026 – Positive feedback from scientific advice meeting in the UK, significantly improved cash flow and discussions with CDMOs on sterile GMP for our Biologics technology initiated – Nanoform small is powerful (nanoform.com)
2026-05-19 — Nanoform Q1 2026 report – Record first quarter revenue, income and gross margin, first exclusivity deal signed around our Biologics technology – Nanoform small is powerful (nanoform.com)
2026-05-12 — Inside information: Nanoform Signs First Exclusivity Agreement for Ultra-High Concentration Subcutaneous Delivery – Nanoform small is powerful (nanoform.com)
2025-11-11 — Inside information made public: Nanoform Granted European Commercial cGMP Manufacturing License – Nanoform small is powerful (nanoform.com)
2025-10-27 — Nanoform Partners With Revio Therapeutics To Develop Long-Acting Locally-Delivered Hydrogel Nanoformulation To Treat Glioma – Nanoform small is powerful (nanoform.com)
2025-10-14 — Nanoform Outlicenses Nanoencorafenib and Signs Development and Commercialisation Agreement with A.forall and IMGA – Nanoform small is powerful (nanoform.com)
Facilities
Nanoform is headquartered in Helsinki, Uusimaa. Public sources also reference these locations:
Helsinki, Finland — nanoform.com
Company details
Nanoform operates as a spinout from the University of Helsinki and holds a European commercial cGMP manufacturing license granted in 2025. Nanoform was founded in 2015, has an estimated 100-200 employees, and is headquartered in Helsinki, Uusimaa.
Frequently asked questions
What does Nanoform do?
Nanoform is a biotechnology and nanotechnology company founded in 2015 and headquartered in Helsinki, Finland, with 100–200 employees. It specializes in nanoparticle engineering and drug formulation services for the pharmaceutical, automotive, electric vehicle, medical, and renewable energy industries. The company operates proprietary CESS® technology to create active pharmaceutical ingredient nanoparticles as small as 10 nanometers, and recently secured its first exclusivity agreement for ultra-high concentration subcutaneous delivery applications.
Where is Nanoform headquartered?
Nanoform is headquartered in Helsinki, Uusimaa (4 Viikinkaari, Helsinki, Uusimaa, 00790).
When was Nanoform founded?
Nanoform was founded in 2015.
How big is Nanoform?
Nanoform has an estimated 100-200 employees, with revenue in the <$10M range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
